Medical information Clinical review pending

Genetic Testing

TRIM32 Gene Bardet-Biedl Syndrome Type 11 Genetic Test

Genetic test to identify mutations in the TRIM32 gene associated with Bardet-Biedl syndrome (BBS). Helps in early detection and management of this hereditary condition.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Blood sample (EDTA tube), Extracted DNA, or One drop of blood on an FTA card.
Results: 3 to 4 weeks. Confirm with the laboratory before booking.
Preparation: Clinical history of the patient is required. A genetic counseling session to draw a pedigree chart of affected family members is recommended prior to testing.

Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the TRIM32 Gene Bardet-Biedl Syndrome Type 11 Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Individuals with symptoms suggestive of Bardet-Biedl syndrome (e.g., obesity, retinal degeneration, polydactyly, kidney abnormalities).
✓Individuals with a family history of Bardet-Biedl syndrome.
✓Carrier screening in families with a known history of TRIM32-related BBS.
✓Prenatal diagnosis if a parent is a known carrier or affected.
✓Confirmation of diagnosis when clinical suspicion is high.

In plain language

What this test helps you understand

This test identifies mutations in the TRIM32 gene, which are a known cause of Bardet-Biedl syndrome. It can help confirm a diagnosis in individuals with symptoms suggestive of BBS, particularly when there is a family history of the condition. Results can inform prognosis, management strategies, and genetic counseling for affected individuals and their families.

The TRIM32 Gene Bardet-Biedl Syndrome Type 11 NGS Genetic DNA Test is a diagnostic tool used to identify mutations in the TRIM32 gene. Mutations in this gene are linked to Bardet-Biedl syndrome (BBS), a genetic disorder characterized by various symptoms including obesity, vision loss due to retinal degeneration, kidney problems, and extra fingers or toes (polydactyly). Early detection through genetic testing can be important for managing the condition and understanding potential health risks. This test analyzes a DNA sample to determine if specific mutations associated with BBS are present. Understanding your genetic predisposition can help guide health management and family planning decisions. Discussing the results with a healthcare professional or genetic counselor is crucial for interpreting the findings and understanding their implications.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationClinical history of the patient is required. A genetic counseling session to draw a pedigree chart of affected family members is recommended prior to testing.

SampleBlood sample (EDTA tube), Extracted DNA, or One drop of blood on an FTA card.

MethodologyNext Generation Sequencing (NGS) of the TRIM32 gene.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test only analyzes the TRIM32 gene. Bardet-Biedl syndrome can be caused by mutations in other genes (BBS1-BBS20). A negative result for TRIM32 does not rule out BBS if caused by mutations in other genes. The test may not detect all possible mutations within the TRIM32 gene. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

Bardet-Biedl syndrome (BBS) is a rare genetic disorder affecting multiple body systems, often causing vision loss, obesity, extra fingers or toes, kidney problems, and learning difficulties.

This test specifically looks for mutations (changes) in the TRIM32 gene, which is one of the genes that can cause Bardet-Biedl syndrome.

This test is recommended for individuals showing symptoms of BBS, those with a family history of the condition, or those referred by a doctor or genetic counselor.

It is important to discuss your results with a healthcare provider or genetic counselor. They can help you understand what the results mean for your health and your family.

No, this test only analyzes the TRIM32 gene. BBS can be caused by mutations in several other genes. A negative result does not rule out BBS.

A sample can be collected as a blood draw, extracted DNA, or a single drop of blood on a special card (FTA card).

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp